HealthNotableSingle-source
5.2
Takeda expands dengue vaccine supply to Brazil amid El Niño outbreak risk
Valor Econômico·BR · DE·1 day ago
Administrative and medical assessment costs for the UK's Vaccine Damage Payment Scheme have surpassed £83 million, more than double the total compensation paid to victims. The figures highlight a growing fiscal and operational burden on a public health program, raising questions about scheme efficiency and resource allocation. The development is notable for its scale but does not signal a change in policy or immediate market impact.